Join
Live feed
·
INSIDERFilingvia Quantisnow
Tenax Therapeutics Inc. logo

CEO Giordano Christopher Thomas bought $20,087 worth of shares (10,850 units at $1.85), increasing direct ownership by 96% to 22,174 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TENX· Tenax Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TENX (Tenax Therapeutics Inc.) and more on Quantisnow.